Le Lézard

Foundayotm (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.

Eli Lilly and Company today announced that Foundayotm (orforglipron) is now available to adults with obesity or overweight with weight-related medical problems following the U.S. Food and Drug ...
Lupus Science & Medicine

Lectin pathway of complement in SLE: MAP-1 as a marker of haematological manifestations and elevated type I interferon activity

Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...
RMD Open

Emotional well-being at diagnosis may indicate future mental health risk in patients with juvenile idiopathic arthritis: data from the German inception cohort ICON

Objectives To determine the prevalence of depressive and anxiety symptoms among young people 7 years and 9 years after ...
GOLDINVEST.de

EcoGraf Refines Tanzania Gold Strategy and Initiates Farm-in with AngloGold

The Australian EcoGraf (WKN A2PW0M / ASX EGR) is bringing its gold activities in Tanzania into sharper focus, combining two ...